Krolewiecki, A. J., Enbiale, W., Gandasegui, J., van Lieshout, L., Kepha, S., Messa Junior, A., . . . Muñoz, J. (2022). An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Web
Citación estilo ChicagoKrolewiecki, Alejandro Javier, et al. An Adaptive Phase II/III Safety and Efficacy Randomized Controlled Trial of Single Day or Three-day Fixed-dose Albendazole-ivermectin Co-formulation Versus Albendazole for the Treatment of Trichuris Trichiura and Other STH Infections. ALIVE Trial Protocol. 2022.
Cita MLAKrolewiecki, Alejandro Javier, et al. An Adaptive Phase II/III Safety and Efficacy Randomized Controlled Trial of Single Day or Three-day Fixed-dose Albendazole-ivermectin Co-formulation Versus Albendazole for the Treatment of Trichuris Trichiura and Other STH Infections. ALIVE Trial Protocol. 2022.